Pharmaceutical - Pharmaceutical, Exparel


Current filters:


Popular Filters

Ph III data shows Pacira’ Exparel good as femoral nerve block in knee arthroplasty


US drugmaker Pacira Pharmaceuticals has released additional Phase III data supporting the efficacy and…

ExparelNeurologicalPacira PharmaceuticalsPharmaceuticalResearch

US Senator seeks answers from drugmakers on providing required discounts


US Senator Charles Grassley has written to two drug companies on behalf of an Iowa hospital that is not…

CSL BehringExparelHematologyKcentraNeurologicalNorth AmericaPacira PharmaceuticalsPharmaceuticalPoliticsPricing

Exparel Ph III trial in intercostal nerve block fails to meet primary endpoint


USA-based Pacira Pharmaceuticals (Nasdaq: PCRX) has reported results from its second pivotal, Phase III…

ExparelNeurologicalPacira PharmaceuticalsPharmaceuticalResearch

Back to top